ICTDR · Registering as Listener

International Conference on Type 1 Diabetes Research

29th Oct – 30th Oct 2026 San Francisco, USA Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICTDR
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Conference on Type 1 Diabetes Research conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure

This track will explore the underlying mechanisms that contribute to the onset and progression of type 1 diabetes. Emphasis will be placed on the interplay between genetic predisposition and environmental triggers.

This session will focus on the autoimmune processes that lead to beta-cell destruction in type 1 diabetes. Researchers are encouraged to present findings on immune system dysregulation and potential therapeutic targets.

This track will delve into the genetic determinants associated with type 1 diabetes susceptibility. Discussions will include recent advancements in genomics and their implications for personalized medicine.

This session will highlight the latest clinical trials aimed at improving treatment outcomes for individuals with type 1 diabetes. Participants will share insights on novel therapies and their efficacy in diverse populations.

This track will investigate the identification and validation of biomarkers for early diagnosis and disease progression in type 1 diabetes. The focus will be on how biomarkers can inform treatment strategies and patient management.

This session will cover recent innovations in insulin delivery and formulation for type 1 diabetes management. Presentations will include discussions on the impact of technology on patient adherence and glycemic control.

This track will address the unique challenges faced by children and adolescents with type 1 diabetes. Emphasis will be placed on psychosocial aspects, education, and the transition to adult care.

This session will explore the complex mechanisms that contribute to the complications associated with type 1 diabetes. Researchers will present findings on cardiovascular, renal, and neurological complications.

This track will focus on bridging the gap between laboratory research and clinical application in type 1 diabetes. Discussions will highlight successful case studies and the role of interdisciplinary collaboration.

This session will examine the psychological and social challenges faced by individuals living with type 1 diabetes. Topics will include coping strategies, mental health support, and the impact of diabetes on quality of life.

This track will provide a platform for discussing emerging trends and future research directions in type 1 diabetes. Participants are encouraged to propose innovative ideas and collaborative approaches to advance the field.

COPYRIGHT © 2026 International Conference on Type 1 Diabetes Research. ALL RIGHTS RESERVED